Please assess the completion status of the following clinical trial:

Trial Title: Combining N-of-1 Trials to Assess Fibromyalgia Treatments

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who meet fibromyalgia criteria as defined by the American College of Rheumatology~* No systemic illness (current or past) or other contraindications to taking study medications (e.g. known hypersensitivity)~* Age 18-60~* Patient willingness, and physician agreement, to discontinue CNS medications/NSAIDs/analgesics for 1 week prior to starting their trial~* Patient informed consent and agreement to participate in an N-of-1 trial~Exclusion Criteria:~* Patients who are currently pregnant or who plan to become pregnant during the study period~* Patients with any contraindications to using either amitriptyline or fluoxetine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Patients received each intervention multiple times in random-order crossover design.

Based on this trial design, predict the completion outcome and termination type (if applicable).